Cell-type-specific_JJ
transactivation_NN
of_IN
the_DT
parathyroid_JJ
hormone-related_JJ
protein_NN
gene_NN
promoter_NN
by_IN
the_DT
human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
I_CD
-LRB-_-LRB-
HTLV-I_NN
-RRB-_-RRB-
tax_NN
and_CC
HTLV-II_NN
tax_NN
proteins_NNS
._.

The_DT
human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
I_CD
-LRB-_-LRB-
HTLV-I_NN
-RRB-_-RRB-
and_CC
HTLV-II_NN
Tax_NN
proteins_NNS
are_VBP
potent_JJ
transactivators_NNS
of_IN
viral_JJ
and_CC
cellular_JJ
gene_NN
expression_NN
._.

Using_VBG
deletion_NN
mutants_NNS
,_,
the_DT
downstream_JJ
parathyroid_JJ
hormone-related_JJ
protein_NN
-LRB-_-LRB-
PTHrP_NN
-RRB-_-RRB-
promoter_NN
is_VBZ
shown_VBN
to_TO
be_VB
responsive_JJ
to_TO
both_CC
HTLV-I_NN
and_CC
HTLV-II_NN
Tax_NN
as_RB
well_RB
as_IN
the_DT
AP1\/c-jun_NN
proto-oncogene_NN
._.

Transactivation_NN
of_IN
PTHrP_NN
by_IN
Tax_NN
was_VBD
seen_VBN
in_IN
T_NN
cells_NNS
but_CC
not_RB
in_IN
B-cell_NN
lines_NNS
or_CC
fibroblasts_NNS
._.

A_DT
carboxy_NN
terminal_JJ
Tax_NN
deletion_NN
mutant_NN
was_VBD
deficient_JJ
in_IN
transactivation_NN
of_IN
both_CC
the_DT
PTHrP_NN
and_CC
IL2R_NN
alpha_NN
promoters_NNS
but_CC
not_RB
the_DT
HTLV-I_NN
long_JJ
terminal_JJ
repeat_NN
-LRB-_-LRB-
LTR_NN
-RRB-_-RRB-
._.

Exogenous_JJ
provision_NN
of_IN
NFkB_NN
rescued_VBD
IL2R_NN
alpha_NN
expression_NN
but_CC
not_RB
the_DT
PTHrP_NN
promoter_NN
._.

Thus_RB
,_,
HTLV-I_NN
Tax_NN
,_,
HTLV-II_NN
Tax_NN
,_,
and_CC
c-jun_NN
transactivate_VBP
PTHrP_NN
and_CC
may_MD
contribute_VB
to_TO
the_DT
pathogenesis_NN
of_IN
hypercalcemia_NN
in_IN
adult_JJ
T-cell_NN
leukemia_NN
._.

